DNA vaccines based on chimeric potyvirus-like particles carrying HPV16 E7 peptide (aa 44-60).

Abstract:

:Vaccine strategies for the treatment of human papillomavirus-induced cervical cancer are based mainly on the human papillomavirus 16 E7 (HPV16 E7) oncoprotein. The immunogenicity of the E7 gene has been enhanced by its fusion to many different genes. Here, we linked a short sequence coding for the E7 peptide (aa 44-60) containing immunodominant epitopes for B and T cells to the 3' end of the gene coding for the whole coat protein (CP) of the poty-virus, potato virus A (PVA), and its deleted form (CPdel) with a short C-terminal deletion of 5 amino acids (LGVKG). CP-E7 and CPdel-E7 fusion proteins, just like CP alone, spontaneously assembled into virus-like particles in both procaryotic and eucaryotic cells. The CP-E7 and CPdel-E7 fusion genes induced slightly stronger E7-specific cytotoxic T-lymphocyte responses than the whole E7 gene, although they were still lower than those elicited by the previously constructed fusion gene, Sig/E7GGG/LAMP-1. The E7- and CP-specific antibody responses were not detected in mice vaccinated with CP-E7 and CPdel-E7 fusion genes. The CP-E7 and CPdel-E7 fusion genes protected mice against the development of tumors induced by TC-1 cells producing the E7 antigen and were also effective in the therapeutic setting, i.e. when the vaccination was performed after tumor cell administration. Their antitumor effect was comparable to those of the whole E7 gene and Sig/E7GGG/LAMP-1 fusion gene. There was no relevant difference between immune responses elicited by CP-E7 and CPdel-E7 DNA vaccination.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Pokorna D,Cerovska N,Smahel M,Moravec T,Ludvikova V,Mackova J,Synkova H,Duskova M,Hozak P,Veleminsky J

keywords:

subject

Has Abstract

pub_date

2005-10-01 00:00:00

pages

1045-53

issue

4

eissn

1021-335X

issn

1791-2431

journal_volume

14

pub_type

杂志文章
  • Thymidylate synthase expression levels: a prognostic and predictive role in advanced colorectal cancer.

    abstract::Thymidylate synthase (TS) is the rate-limiting enzyme in the synthesis of pyrimidine nucleotides, required for DNA synthesis, and is also a critical target for fluoropyrimidines, which are widely used in the treatment of gastrointestinal tumours. We examined TS expression in tumours from 86 patients with advanced colo...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.14.3.657

    authors: Bendardaf R,Lamlum H,Elzagheid A,Ristamäki R,Pyrhönen S

    更新日期:2005-09-01 00:00:00

  • CRISPR/Cas9-mediated genome engineering of CXCR4 decreases the malignancy of hepatocellular carcinoma cells in vitro and in vivo.

    abstract::CXC chemokine receptor 4 (CXCR4) is associated with poor clinical outcomes and decreased survival in hepatocellular carcinoma (HCC). In the present study, we targeted CXCR4 by CRISPR/Cas9 in HepG2 cells and observed the effects both in vitro and in vivo. The results indicated that after targeting CXCR4 the expression ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5601

    authors: Wang X,Zhang W,Ding Y,Guo X,Yuan Y,Li D

    更新日期:2017-06-01 00:00:00

  • Curcumin induces apoptosis in human lung adenocarcinoma A549 cells through a reactive oxygen species-dependent mitochondrial signaling pathway.

    abstract::Several studies have shown that curcumin can induce apoptosis and inhibit growth in human A549 lung adenocarcinoma cells. However, the mechanism is not completely understood yet. The present study was designed to investigate the effects of curcumin on A549 cells to better understand its apoptosis and apoptosis-related...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Chen Q,Wang Y,Xu K,Lu G,Ying Z,Wu L,Zhan J,Fang R,Wu Y,Zhou J

    更新日期:2010-02-01 00:00:00

  • Modulation of GemOx chemotherapy according to CIRS in elderly patients with advanced pancreatic cancer.

    abstract::The present study evaluated activity and toxicity of modulated doses of gemcitabine associated to oxaliplatin in patients with secondary CIRS and with locally advanced pancreatic adenocarcinoma (LAPC) and metastatic pancreatic adenocarcinoma (MPC). Since January 2006, untreated LAPC and MPC patients have been assessed...

    journal_title:Oncology reports

    pub_type: 临床试验,杂志文章

    doi:10.3892/or.2011.1517

    authors: Tudini M,Palluzzi E,Cannita K,Mancini M,Santomaggio A,Bruera G,Baldi PL,Pelliccione M,Ricevuto E,Ficorella C

    更新日期:2012-02-01 00:00:00

  • Histone deacetylase inhibitors and aspirin interact synergistically to induce cell death in ovarian cancer cells.

    abstract::Histone deacetylase inhibitors (HDIs) as well as non-steroidal anti-inflammatory drugs including aspirin show promise as antineoplastic agents. The treatment with both HDIs and aspirin can result in hyperacetylation of proteins. In this study, we investigated whether HDIs and aspirin interacted in inducing anticancer ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Sonnemann J,Hüls I,Sigler M,Palani CD,Hong le TT,Völker U,Kroemer HK,Beck JF

    更新日期:2008-07-01 00:00:00

  • Low expression of PinX1 is associated with malignant behavior in basal-like breast cancer.

    abstract::Human Pinx1 protein, associated with shelterin proteins, is widely revealed as a haploinsufficient tumor suppressor. Growing evidence has manifested the deregulation of PinX1 in distinct cancers. Nonetheless, the loss status of PinX1 and its diagnostic, prognostic and clinicopathological significance in Basal-like bre...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5696

    authors: Feng YZ,Zhang QY,Fu MT,Zhang ZF,Wei M,Zhou JY,Shi R

    更新日期:2017-07-01 00:00:00

  • Biological comparison of ovarian cancer resistant cell lines to cisplatin and Taxol by two different administrations.

    abstract::Drug resistance is one of the major obstacles to chemotherapy of ovarian cancer. Studies with cell lines can serve as an initial screen for agents that might modulate drug resistance. To establish more appropriate models of drug resistance and explore whether the differences exist in the different drug resistant subli...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Yan XD,Li M,Yuan Y,Mao N,Pan LY

    更新日期:2007-05-01 00:00:00

  • Treatment with HER-2 phosphorylation agonists enhance tumor ability to stimulate epitope specific CTL in vitro.

    abstract::The transmembrane (TM) receptor encoded by the HER-2 proto-oncogene (HER-2) is amplified in several types of human carcinomas and premalignant states and provides an important target for cancer therapy. While overexpression of HER-2 should lead to increased CTL epitope formation due to the attendant increase in higher...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Castilleja A,Ward NE,Epstein RB,Kudelka AP,Gershenson DM,Efferson CL,O'Brian CA,Ioannides CG

    更新日期:2002-09-01 00:00:00

  • Protocadherin-10 acts as a tumor suppressor gene, and is frequently downregulated by promoter methylation in pancreatic cancer cells.

    abstract::Protocadherin-10 (PCDH10), a member of non-clustered protocadherin family which plays important roles in calcium-dependent cell-cell signal transduction and adhesion. PCDH10 functions as a tumor suppressor gene and its expression is downregulated by promoter methylation in many malignances. In the present study, we ex...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4793

    authors: Qiu C,Bu X,Jiang Z

    更新日期:2016-07-01 00:00:00

  • Emodin inhibits epithelial to mesenchymal transition in epithelial ovarian cancer cells by regulation of GSK-3β/β-catenin/ZEB1 signaling pathway.

    abstract::Emodin (EMO) has been shown to possess pleiotropic anticancer capabilities in many types of cancer, including epithelial ovarian cancer (EOC). Inhibitory efficacy of EMO on EOC invasion and migration was previously observed, however, the underlying mechanisms have not been completely elucidated. The present study is a...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4591

    authors: Hu C,Dong T,Li R,Lu J,Wei X,Liu P

    更新日期:2016-04-01 00:00:00

  • Expression of EphA2 and E-cadherin in colorectal cancer: correlation with cancer metastasis.

    abstract::Recently, overexpression of EphA2, a member of the Eph family of receptor tyrosine kinases, has been reported in several cancers. Reduced expression of E-cadherin, an intercellular adhesion molecule of epithelial cells, has been reported to be associated with aggressive clinicopathological phenotypes in various cancer...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Saito T,Masuda N,Miyazaki T,Kanoh K,Suzuki H,Shimura T,Asao T,Kuwano H

    更新日期:2004-03-01 00:00:00

  • Pathotropic targeting advances clinical oncology: tumor-targeted localization of therapeutic gene delivery.

    abstract::The advent of pathotropic (disease-seeking) targeting has transported genetic medicine across the threshold of history with the progressive clinical validation of Rexin-G, a tumor-targeted nanosized anti-cancer agent. Achieving noteworthy single-agent efficacy and survival benefits in otherwise intractable cancers, th...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2010.829

    authors: Hall FL,Levy JP,Reed RA,Petchpud WN,Chua VS,Chawla SP,Gordon EM

    更新日期:2010-10-01 00:00:00

  • An eight-long non-coding RNA signature as a candidate prognostic biomarker for lung cancer.

    abstract::Cumulative evidence suggests that long non-coding RNAs (lncRNAs) may be good biomarkers in various types of tumors. In the present study, we mined lncRNA expression profiling in 739 lung cancer patients from Gene Expression Omnibus (GEO) datasets. A risk score model was constructed based on the expression data of thes...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4817

    authors: Tu Z,He D,Deng X,Xiong M,Huang X,Li X,Hao L,Ding Q,Zhang Q

    更新日期:2016-07-01 00:00:00

  • c-erbB-2 protein expression and clinicopathologic features in colorectal cancer.

    abstract::Previous reports showed that breast and gastric cancers overexpressing c-erbB-2 protein have a greater metastatic potential and worse prognosis than tumors in which this protein is not overexpressed. The present study was undertaken to examine the significance of c-erbB-2 protein expression as a prognostic factor in c...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.7.6.1229

    authors: Ishida H,Sadahiro S,Suzuki T,Ishikawa K,Tajima T,Makuuchi H

    更新日期:2000-11-01 00:00:00

  • The antitumor effect of human cord blood-derived dendritic cells modified by the livin α gene in lung cancer cell lines.

    abstract::The growth of malignant tumors is associated with mechanisms of immune escape and inhibition of apoptosis. Livin is a novel member of the inhibitors of apoptosis (IAP) protein family that inhibits cell apoptosis. Livin is specifically expressed by the majority of tumor cells, but it is not expressed in normal adult ti...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2133

    authors: Chen H,Jin Y,Chen T,Zhang M,Ma W,Xiong X,Tao X

    更新日期:2013-02-01 00:00:00

  • Functional analysis of protein disulfide isomerase P5 in glioblastoma cells as a novel anticancer target.

    abstract::P5, which is a member of the protein disulfide isomerase family, possesses isomerase and chaperone activity in vitro; however, the physiological functions of this enzyme in cells remain unclear. To understand the important roles of P5 in cancer cells, the present study examined its expression on the surface of normal ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6868

    authors: Horibe T,Torisawa A,Masuda Y,Kawakami K

    更新日期:2019-02-01 00:00:00

  • Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR.

    abstract::The present study determined the anticancer activity and its mechanism of microRNA‑133b on cell proliferation of cisplatin-induced non-small cell lung cancer cells. The expression of microRNA-133b cisplatin‑induced non-small cell lung cancer (NSCLC) tissue was lower than that of para-carcinoma tissue in patients. Over...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6215

    authors: Li B,Ding CM,Li YX,Peng JC,Geng N,Qin WW

    更新日期:2018-03-01 00:00:00

  • Magnetic resonance angiography without contrast enhancement medium in bone and soft tissue tumors.

    abstract::The aim of this study was to assess the ability of a new magnetic resonance (MR) angiography technique that does not use contrast enhancement medium to depict the vascularity of musculoskeletal neoplasms, and evaluate its clinical utility. We performed 3D fresh blood imaging (FBI) MR angiography in 57 patients with bo...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Doi H,Ono A,Kawai A,Morimoto Y,Kunisada T,Nakata E,Ozaki T

    更新日期:2006-03-01 00:00:00

  • A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancer.

    abstract::The majority of patients with hormone receptor-positive metastatic breast cancer die from disease progression despite different types of anti-hormonal treatments. Preclinical studies have indicated that resistance to anti-hormonal therapies may be the result of an activated NF-κB si...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1562

    authors: Trinh XB,Sas L,Van Laere SJ,Prové A,Deleu I,Rasschaert M,Van de Velde H,Vinken P,Vermeulen PB,Van Dam PA,Wojtasik A,De Mesmaeker P,Tjalma WA,Dirix LY

    更新日期:2012-03-01 00:00:00

  • Extraskeletal Ewing's sarcoma of the thoracic epidural space: case report and review of the literature.

    abstract::The occurrence of primary extraskeletal Ewing's sarcoma (EES) of the spinal epidural space has been rarely reported in the literature. The clinical, radiologic and pathologic features of a case of EES occurring in the thoracic epidural space are presented. A 37-year-old woman presented with a one-year history of back ...

    journal_title:Oncology reports

    pub_type: 杂志文章,评审

    doi:10.3892/or.2011.1326

    authors: Yasuda T,Suzuki K,Kanamori M,Hori T,Huang D,Bridge JA,Kimura T

    更新日期:2011-09-01 00:00:00

  • A quadruple therapy synergistically blocks proliferation and promotes apoptosis of hepatoma cells.

    abstract::Effective therapy for advanced hepatocellular carcinoma (HCC) is lacking. Conventional chemotherapy was judged to be ineffective. We previously demonstrated that the histone deacetylase inhibitor Trichostatin A (TSA) blocks growth of HCC cells in vitro. The anti-tumoral effect of a combination of more than 2 classes o...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Ganslmayer M,Ocker M,Zopf S,Leitner S,Hahn EG,Schuppan D,Herold C

    更新日期:2004-05-01 00:00:00

  • Lung cancer patients with chronic obstructive pulmonary disease.

    abstract::The aim of this study is to evaluate characteristics in lung cancer patients with chronic obstructive pulmonary disease (COPD). Among 966 lung cancer patients admitted to our division over a period of 24 years, 73 patients were diagnosed as having COPD. There were 68 (93.2%) men and 5 women; of the tumors 43 (58.9%) w...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Kurishima K,Satoh H,Ishikawa H,Yamashita YT,Homma T,Ohtsuka M,Sekizawa K

    更新日期:2001-01-01 00:00:00

  • Overexpression of CPXM2 predicts an unfavorable prognosis and promotes the proliferation and migration of gastric cancer.

    abstract::Carboxypeptidase X, M14 family member 2 (CPXM2), has been associated with several human disorders such as developmental diseases. However, whether CPXM2 is involved in oncogenesis or tumor progression remains unclear. In the present study, we used clinical samples from gastric cancer (GC) patients to investigate poten...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7254

    authors: Niu G,Yang Y,Ren J,Song T,Hu Z,Chen L,Hong R,Xia J,Ke C,Wang X

    更新日期:2019-10-01 00:00:00

  • A matrix metalloproteinase inhibitor enhances anti-cytotoxic T lymphocyte antigen-4 antibody immunotherapy in breast cancer by reprogramming the tumor microenvironment.

    abstract::Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) treatment is effective for the treatment of primary tumors, but not sufficient for the treatment of metastatic tumors, likely owing to the effects of the tumor microenvironment. In this study, we aimed to determine the therapeutic effects of combined treatment with a matr...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4547

    authors: Li M,Xing S,Zhang H,Shang S,Li X,Ren B,Li G,Chang X,Li Y,Li W

    更新日期:2016-03-01 00:00:00

  • Reduced expression of SRY-box containing gene 17 correlates with an unfavorable melanoma patient survival.

    abstract::SRY-box containing gene 17 (Sox17), a transcription factor, is considered as an antagonist to canonical Wnt/β‑catenin signaling in several types of malignant tumors. As the influence of Sox17 in the pathogenesis of human melanoma is still unknown, the investigation of Sox17 expression in melanoma is warranted and its ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3534

    authors: Lu J,Zhang G,Cheng Y,Tang Y,Dong Z,McElwee KJ,Li G

    更新日期:2014-12-01 00:00:00

  • Mapping of the critical region of mitogene-inducible gene-6 for NF-kappaB activation.

    abstract::Mitogene-inducible gene-6 (Mig-6) is involved in the intracellular signaling pathway as an adaptor molecule. Mig-6 expression is rapidly induced upon various kinds of mitogenic and stressful stimulations. We previously demonstrated that Mig-6 expression is induced by activated Ki-ras in human colon cancer cells and th...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Mabuchi R,Sasazuki T,Shirasawa S

    更新日期:2005-03-01 00:00:00

  • Differential expression of heat shock protein 27 in normal oral mucosa, oral epithelial dysplasia and squamous cell carcinoma.

    abstract::The aim of this study was to evaluate HSP27 expression in fetal, normal and inflamed oral mucosal epithelium and in oral premalignant epithelial lesions and in their ensuing invasive cancers. In developing human oral epithelia, immunoreactions for HSP27 were moderately observed in suprabasal keratinocytes of palate an...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Leonardi R,Pannone G,Magro G,Kudo Y,Takata T,Lo Muzio L

    更新日期:2002-03-01 00:00:00

  • Characterizing the molecular mechanisms of acquired temozolomide resistance in the U251 glioblastoma cell line by protein microarray.

    abstract::Acquired chemoresistance refers to tumor cells gradually losing their sensitivity to anticancer drugs during the course of treatment, resulting in tumor progression or recurrence. This phenomenon, which has deleterious outcomes for the patient, has long been observed in patients with glioblastoma receiving temozolomid...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6322

    authors: Lin J,Zuo J,Cui Y,Song C,Wu X,Feng H,Li J,Li S,Xu Q,Wei W,Qiu G,He H

    更新日期:2018-05-01 00:00:00

  • Vinblastine differs from Taxol as it inhibits the malignant phenotypes of NSCLC cells by increasing the phosphorylation of Op18/stathmin.

    abstract::Taxol (paclitaxel) and vinblastine (VBL) are both efficacious chemotherapeutic agents that target the microtubules of tumor cells, but each functions in a mutual antagonistic manner. Op18/stathmin is a small molecular phosphoprotein which promotes depolymerization of microtubules. Non-small cell lung cancer (NSCLC) NC...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5469

    authors: Shen F,Long D,Yu T,Chen X,Liao Y,Wu Y,Lin X

    更新日期:2017-04-01 00:00:00

  • Recurrence and 5-FU sensitivity of stage III/Dukes' C colorectal cancer with occult neoplastic cells in lymph node sinuses.

    abstract::In 72 patients without occult neoplastic cells (ONCs) in their lymph node sinuses, the 5-year relapse-free survival (RFS) rate and overall survival (OS) rate were 71.3% and 69.2%, respectively. In 33 patients with ONCs, the 5-year RFS rate and OS rate were 33.9% and 31.3%, respectively. There was a marked difference o...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Mukai M,Sato S,Ninomiya H,Wakui K,Komatsu N,Tsuchiya K,Nakasaki H,Makuuchi H

    更新日期:2005-11-01 00:00:00